医学博士，上海交通大学医学院心血管内科学博士生导师，上海市高血压研究所所长，上海交通大学医学院附属瑞金医院高血压科主任。
主要从事高血压临床诊治与研究工作。提出“高血压病因学分型诊治”的理念，致力于建设“智慧化高血压治疗中心”，推动“高血压分级、分期和分型管理”。截至2022年8月，全文发表英文论著或综述540篇，中文论著与综述190篇。
兼任中国高血压联盟（CHL）主席，中国医师协会高血压专业委员会副主任委员。国际高血压学会前执委，亚太高血压学会（APSH）前主席，亚洲动脉学会（POA）前主席。Journal of Clinical Hypertension杂志主编，Hypertension杂志副主编，Hypertension Research杂志副主编，《中华心血管病杂志》副总编，《中华高血压杂志》副主编。
Videos：0
Abstracts：12
7625
0
0
| Date | Time | Local Time | Room | Session | Role | Topic |
|---|---|---|---|---|---|---|
| 2020-10-19 | 09:00-09:20 | 2020-10-19,09:00-09:20 | Interpretation of Clinical Research and Guideline Channel |
Hypertension: Guideline Interpretation & Clinical Implication-I |
Speaker | Most Recent Guidelines of Hypertension: Focus on Clinical Diagnosis |
| 2020-10-19 | 09:44-09:59 | 2020-10-19,09:44-09:59 | Hypertension Channel |
Highlights on Hypertension |
Speaker | Significance and Problems of Primary Aldosteronism Screening in Hypertension Management? |
| 2020-10-19 | 16:00-16:05 | 2020-10-19,16:00-16:05 | Heart Failure and Cardiomyopathy Channel |
【Symposium】Salubris Symposium: Interpretation of 2020 ESC Guideline |
Discussant | Opening Speech |
| 2020-10-19 | 16:00-17:30 | 2020-10-19,16:00-17:30 | Heart Failure and Cardiomyopathy Channel |
【Symposium】Salubris Symposium: Interpretation of 2020 ESC Guideline |
Moderator | |
| 2020-10-19 | 16:05-16:10 | 2020-10-19,16:05-16:10 | Heart Failure and Cardiomyopathy Channel |
【Symposium】Salubris Symposium: Interpretation of 2020 ESC Guideline |
Discussant | Agenda and Expert Introduction |
| 2020-10-19 | 17:25-17:30 | 2020-10-19,17:25-17:30 | Heart Failure and Cardiomyopathy Channel |
【Symposium】Salubris Symposium: Interpretation of 2020 ESC Guideline |
Discussant | Summary |
| 2020-10-20 | 19:20-19:40 | 2020-10-20,19:20-19:40 | Hypertension Channel |
Basic Research on Hypertension (1) |
Speaker | The Molecular Mechanism of NPR3 in Hypertension |
| 2020-10-21 | 11:00-12:30 | 2020-10-21,11:00-12:30 | Prevention and Rehabilitation Channel |
Antihypertensive Treatments: Details Determine Success or Failure |
Moderator | |
| 2020-10-21 | 11:00-11:15 | 2020-10-21,11:00-11:15 | Prevention and Rehabilitation Channel |
Antihypertensive Treatments: Details Determine Success or Failure |
Speaker | Antihypertensive Treatments: Who Needs Pharmaceutical Therapies? |
| 2020-10-21 | 15:12-15:27 | 2020-10-21,15:12-15:27 | Hypertension Channel |
Blood Pressure Measurement and Management |
Speaker | 2019 Chinese Hypertension League Home Blood Pressure Monitoring Guideline |
| 2020-10-22 | 14:00-15:30 | 2020-10-22,14:00-15:30 | Hypertension Channel |
Big Data, Artificial Intelligence and Internet in Hypertension Management |
Moderator | |
| 2020-10-22 | 14:00-14:15 | 2020-10-22,14:00-14:15 | Hypertension Channel |
Big Data, Artificial Intelligence and Internet in Hypertension Management |
Speaker | Prospect of Hypertension Management in the Era of Cloud Computing and Big Data |
| 2020-10-23 | 19:00-21:00 | 2020-10-23,19:00-21:00 | Meet the Experts |
Hypertension Management: Revolution and Challenge |
Moderator | |
| 2020-10-25 | 09:00-10:30 | 2020-10-25,09:00-10:30 | Hypertension Channel |
Interpretation of Hypertension Guidelines |
Moderator | |
| 2020-10-25 | 09:22-09:37 | 2020-10-25,09:22-09:37 | Hypertension Channel |
Interpretation of Hypertension Guidelines |
Speaker | Global Impact of Recent US and European Hypertension Guidelines |
| 2020-10-25 | 11:00-12:30 | 2020-10-25,11:00-12:30 | Hypertension Channel |
【Symposium】Jibeier Symposium: CCB + BB Combined Rate Control Therapy in Young and Middle-aged Patients with Hypertension |
Moderator | |
| 2020-10-25 | 14:00-15:30 | 2020-10-25,14:00-15:30 | Hypertension Channel |
Blood Pressure Management in Special Population |
Moderator |